Dementia  >>  memantine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
memantine / Generic mfg.
NCT00624026 / 2006-003616-21: Memantine - Communication Study

Completed
3
107
Europe
Memantine-HCl
Merz Pharmaceuticals GmbH
Alzheimer's Disease
12/08
12/08
NCT00804271 / 2008-005144-16: Memantine and Validation of a New Alzheimer's Disease Scale

Completed
3
487
Europe
memantine, Axura
Merz Pharmaceuticals GmbH
Alzheimer's Disease
11/09
11/09
NCT00857649: Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease

Terminated
3
369
Canada
Memantine, Ebixa®, Placebo
H. Lundbeck A/S
Alzheimer's Disease
04/10
09/10
NCT00857233: Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease

Terminated
3
297
Canada
Memantine, Ebixa®
H. Lundbeck A/S
Alzheimer's Disease
07/10
10/10
NCT00594737: Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia

Completed
3
17
Canada
memantine hydrochloride, Ebixa, Namenda
Tiffany Chow, MD, H. Lundbeck A/S
Frontotemporal Dementia
06/12
06/12

Download Options